Skip to main content

Should Big Pharma spend more on marketing than R&D? – MedCity News

By December 16, 2016News
pharma-drugs-pixa

pharma-drugs-pixa

Nineteen. That’s the number of new drugs approved by the FDA thus far in 2016. With just over two weeks to go, there is little hope for a stellar year like 2015, which yielded 45 approvals.

What gives?

{iframe}http://medcitynews.com/2016/12/big-pharma-marketing-rd/?utm_source=hs_email&utm_medium=email&utm_content=39234262&_hsenc=p2ANqtz-_FO4F0P9V9bhvkgQx1G9EBvusBlptFmd0s1Tg4THkaldTpIculUcA1dsK0yKXQLWRV6UaYs3KiiWpTvQrj-dp11B8i6w&_hsmi=39234262{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.